MedTrace Logo

Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer

NCT03181035 · Status: SUSPENDED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-08-12

No results posted yet for this study

Summary

This is a pilot study in the form of a prospective Phase II, single centre, single arm hypoxia study of oral tongue cancer with FAZA-PET imaging and pimonidazole targeted IHC of surgical specimens.

Conditions

  • Tongue Cancer

Interventions

RADIATION

(18)F-Fluoroazomycin arabinoside

FAZA PET diagnostic testing

DRUG

Pimonidazole

oral pimonidazole hypoxia labeling

Sponsors & Collaborators

  • Sunnybrook Research Institute

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Ian Poon, MD, FRCPC · Sunnybrook Health Sciences Centre

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-25
Primary Completion
2024-09-30
Completion
2024-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03181035 on ClinicalTrials.gov